Latest monoclonal antibodies News

Patient enrolment begins in a scientific trial to identify the first effective treatments for Bundibugyo virus disease
Experts convened by WHO advise on candidate treatments and vaccines for Ebola disease caused by Bundibugyo virus
Anthrax-causing bacteria have dwelled in soil for centuries – cycling through people, animals and earth
HKUST Researchers Develop Metastasis Prevention Therapy Based on Glycan Targeting
Why Canada’s next big infrastructure investment should be in biomanufacturing
QIMR Berghofer Science Powers Breakthrough In Cancer Immunotherapy
Free Immunisation To Protect Babies From RSV Next Year
WHO publishes new R&D landscape analyses highlighting gaps and inequities in cancer research
Champion tennis player Monica Seles has myasthenia gravis – what is it and how does it affect sufferers?
Bioengineered bacteria could lead to therapeutic antibody drugs
Lyssavirus is rare, but deadly. What should you do if a bat bites you?
WHO outlines recommendations to protect infants against RSV – respiratory syncytial virus
‘Super antibodies’ for snake toxins: how a dangerous DIY experiment helped scientists make a new antivenom
First targeted treatment on the PBS for rare, unpredictable and debilitating autoimmune disease, NMOSD
WHO prequalifies first maternal respiratory syncytial virus vaccine
Biosimilars: expanding access to essential biologic therapies
What is Sudan virus and how similar is it to Ebola?
Camp Hill virus explained: what are the risks of a henipavirus outbreak in America?
Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment
hMPV may be spreading in China. Here’s what to know about this virus – and why it’s not cause for alarm
Scientists Discover New Receptor for Nerve Growth Factor-a Promising Target for Treating Pain
Message by the Director of the Department of Immunization, Vaccines and Biologicals at WHO – September/October 2024
Government’s free RSV immunisations will keep babies out of hospital: RACGP
Virtual screening IDs potential small molecule drugs for cancer immunotherapy
GPs commend Victorian Government for taking action on RSV
Protecting Victorian Newborns And Infants Next Winter
Research backs RACGP calls for ‘living’ long COVID guidelines
Center for NextGen Therapeutics helps match researchers to molecules
RSV is linked to asthma in children – but we can’t say one causes the other yet
Epitope Binning-seq: A Game-Changer in Antibody Drug Discovery Researchers pioneer a novel method, enabling simultaneous analysis of multiple antibodies, revolutionizing drug discovery…
Telix completes proof-of-concept study of TLX592 in prostate cancer
Future Cancer Treatment And Fertility
Babies in WA will soon be immunised against RSV – but not with a vaccine
Springfield Steps Up To Fight Breast Cancer
Promising Development for Breast Cancer Patients
Australian scientist recognised as emerging talent
WHO endorses landmark public health decisions on Essential Medicines for Multiple Sclerosis
Alzheimer’s drug donanemab has been hailed as a ‘turning point’ for treatment. But what does it mean for people with the disease?
Nirsevimab unanimously recommended by FDA Advisory Committee for the prevention of RSV lower respiratory tract disease in infants
WHO and Republic of Korea sign landmark agreement to boost biomanufacturing capacity
Wonder drug-capsule may one day replace insulin injection for diabetics
Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi
Antibody targets omicron and other SARS-CoV-2 variants
Update on effectiveness of monoclonal antibodies against COVID variants
New tool in arsenal against Covid is being put to t
Monash University and Ono Pharmaceutical Announce Collaboration Agreement
What are skeletal related events?
Beyfortus approved in EU for prevention of RSV lower respiratory tract disease in infants